Pregnancy Physiology
A woman in her third trimester moves roughly 7 liters of blood per minute through her heart. This is up from 5 liters before conception. Her thyroid works harder, and her kidneys filter more. An organ that did not exist nine months earlier — the placenta — now secretes more steroid hormone per day than her ovaries ever did. None of this is incidental plumbing. It is a coordinated, hormonally driven remodeling of nearly every organ system. This remodeling is executed on a strict timetable. It is reversed within weeks of delivery. Understanding how this happens answers a question central to reproductive medicine. How does a mother's body sustain, nourish, and eventually expel a genetically foreign tissue? It must do so without rejecting it or collapsing under its metabolic demand. Pregnancy physiology sits at the intersection of endocrinology, cardiovascular physiology, and immunology. It builds directly on the ovarian and uterine cycles established before conception. The placenta is not a passive filter. It is an endocrine organ in its own right. It hijacks and extends the corpus luteum's job, then eventually replaces it entirely. Maternal organs respond to placental signals with certain adaptations. These look pathological outside pregnancy — dilated blood vessels, insulin resistance, hyperventilation. But they are precisely tuned to feed a growing fetus. At the end, a second hormonal cascade dismantles the arrangement. This happens in the tightly choreographed process of parturition. The stakes are high. Disorders of these systems — preeclampsia, gestational diabetes, preterm labor — are leading causes of maternal and neonatal morbidity worldwide. Grasping the normal mechanism is the prerequisite for understanding every one of these pathologies. It is also necessary for interpreting the blood tests used to monitor pregnancy. These include hCG, progesterone, and estriol. Clinical signs are also used, such as blood pressure, fundal height, and fetal heart rate. This article traces the mechanism from implantation-driven hCG secretion through the "luteal-placental shift." It moves across the major maternal adaptations organ system by organ system. It continues into the positive-feedback cascade of labor. It grounds each claim in the classic experiments and clinical observations that established it. Then it works through two quantitative clinical scenarios.
- The placenta secretes hCG, progesterone, estrogens, and human placental lactogen (hPL), taking over corpus luteum function by ~7–9 weeks (the luteal-placental shift).
- hCG rescues the corpus luteum from luteolysis by mimicking LH at its receptor; this is the basis of all urine pregnancy tests.
- Progesterone maintains the endometrium and keeps the myometrium quiescent by suppressing gap junctions and oxytocin receptors ("progesterone block").
- Maternal cardiac output rises ~30–50%, blood volume expands ~40–50%, and physiological anemia, hyperventilation, and insulin resistance are normal adaptations, not disease.
- Parturition is driven by a positive-feedback loop: rising estrogen-to-progesterone ratio, stretch, oxytocin, and prostaglandins reinforce uterine contractions until delivery.
- Preeclampsia and gestational diabetes are the two most important pathological deviations from normal placental and metabolic adaptation, both diagnosable from the mechanisms covered here.
The placenta converts pregnancy from a corpus-luteum-dependent state into a self-sustaining endocrine system, and labor begins only once that system's hormonal brake — progesterone dominance — is overridden by a rising estrogen and oxytocin/prostaglandin drive.
The core idea
Pregnancy is maintained by a continuously shifting hormonal partnership between the corpus luteum and the placenta. Early on, the blastocyst implants and its outer trophoblast layer begins secreting human chorionic gonadotropin (hCG), a glycoprotein hormone structurally similar to luteinizing hormone (LH). Because the corpus luteum formed after ovulation would otherwise degenerate (luteolysis) roughly 12–14 days after ovulation, hCG's job is to bind LH receptors on the corpus luteum and rescue it, keeping it alive and hormonally active for another 8–10 weeks. This corpus luteum, now called the corpus luteum of pregnancy, continues producing progesterone and estrogen, which are absolutely required to maintain the endometrial lining (decidua) against menstrual shedding. As pregnancy proceeds, the placenta itself matures into a steroid-secreting organ and gradually assumes the hormonal burden, a transition called the luteal-placental shift, complete by about 7–9 weeks gestation. After this point the corpus luteum can be surgically removed without terminating the pregnancy — a fact demonstrated experimentally and clinically decades ago. The placenta lacks some enzymes needed for complete steroid synthesis from scratch, so it operates as part of a fetoplacental unit: cholesterol from the mother is converted to progesterone in placental syncytiotrophoblast, while estrogen synthesis requires androgen precursors (dehydroepiandrostenedione sulfate, DHEA-S) supplied by both the maternal and fetal adrenal glands, aromatized in the placenta. This division of labor means maternal estriol levels are, in effect, a readout of fetal adrenal and hepatic function. The other core idea is that maternal physiology does not merely tolerate pregnancy — it actively remodels itself, under instruction from placental hormones (progesterone, estrogen, hPL, relaxin) and rising metabolic demand, to become a life-support system for the fetus. Terms like "physiological anemia of pregnancy" and "gestational insulin resistance" describe adaptive, hormonally engineered states, not disease, though the same mechanisms can tip into pathology (preeclampsia, gestational diabetes) when regulation fails.
Mechanism
Step 1 — Implantation and hCG secretion. Around day 6–10 after fertilization, the blastocyst's outer trophoblast cells invade the endometrium and differentiate into cytotrophoblast and syncytiotrophoblast. The syncytiotrophoblast begins secreting hCG almost immediately; it is detectable in maternal blood by about day 8 post-ovulation and in urine shortly after, which is why home pregnancy tests can give positive results even before a missed period.
Step 2 — Corpus luteum rescue. hCG binds the same G-protein-coupled LH receptor on granulosa-lutein cells that LH normally occupies. This receptor signals through Gs → adenylyl cyclase → cAMP → protein kinase A, driving continued cholesterol side-chain cleavage and progesterone synthesis. Without hCG, LH support collapses roughly two weeks post-ovulation (the normal luteal phase length), the corpus luteum regresses, progesterone falls, and the endometrium sloughs as menses. hCG prevents exactly this collapse, holding progesterone and estrogen secretion above the threshold needed to maintain the decidua.
Step 3 — hCG kinetics. Maternal hCG doubles roughly every 48–72 hours in early pregnancy, peaks around 8–10 weeks at roughly 50,000–100,000 mIU/mL, then declines and plateaus around 20,000 mIU/mL for the remainder of gestation. The peak coincides almost exactly with the point at which the corpus luteum's job becomes largely redundant — a temporal correlation that is part of the evidence for the luteal-placental shift.
Step 4 — The luteal-placental shift. By 7–9 weeks, the placenta's own syncytiotrophoblast produces enough progesterone directly from maternal LDL-cholesterol that hCG-driven corpus luteum output becomes unnecessary. Progesterone in maternal serum, sourced increasingly from the placenta rather than the ovary, continues rising steadily across gestation, reaching roughly 100–200 ng/mL at term (compared to ~10–20 ng/mL in the luteal phase of a non-pregnant cycle).
Step 5 — Estrogen synthesis via the fetoplacental unit. The placenta cannot synthesize estrogens de novo because it lacks 17α-hydroxylase/17,20-lyase activity. Instead, maternal and fetal adrenal glands produce DHEA-S; the fetal liver hydroxylates it further; and the placental syncytiotrophoblast aromatizes these androgen precursors into estrone, estradiol, and especially estriol, whose levels rise roughly 1,000-fold over pregnancy and depend almost entirely on a living, functioning fetus — making maternal estriol a clinical marker of fetal well-being.
Step 6 — Human placental lactogen (hPL) and metabolic reprogramming. The placenta also secretes hPL (also called human chorionic somatomammotropin), a growth-hormone-like peptide that rises steadily across gestation. hPL antagonizes maternal insulin action on peripheral tissues (muscle, adipose), promoting maternal insulin resistance. This is adaptive: by making maternal cells relatively insulin-resistant, hPL diverts glucose and free fatty acids toward the fetus, especially during maternal fasting states, while maternal beta cells compensate with a roughly two- to threefold increase in insulin secretion. When pancreatic compensation is inadequate, gestational diabetes mellitus results.
Step 7 — Progesterone's uterine quiescence effect. Throughout gestation, high progesterone suppresses myometrial excitability by inhibiting the formation of gap junctions between smooth muscle cells (reducing electrical coupling), decreasing oxytocin receptor expression, and lowering prostaglandin synthesis. This "progesterone block" keeps the uterus relaxed despite its enormous stretch, and its withdrawal (functional, not always an absolute drop in humans) is a prerequisite for labor.
Step 8 — Relaxin and connective tissue remodeling. The corpus luteum and placenta also secrete relaxin, which softens the cervix, loosens pelvic ligaments, and works with progesterone to keep the myometrium quiescent, preparing the birth canal without yet permitting contraction.
Step 9 — Maternal cardiovascular remodeling. Estrogen and progesterone (and the low-resistance placental circulation itself) drive systemic vasodilation, dropping total peripheral resistance. Renin-angiotensin-aldosterone system activity increases (with resistance to angiotensin II's pressor effect, so blood pressure does not simply rise). Blood volume expands by roughly 40–50% (about 1,200–1,600 mL added), driven by estrogen-stimulated renin/aldosterone-mediated sodium and water retention. Cardiac output rises 30–50%, mostly via increased stroke volume in the first half of pregnancy and increased heart rate later. Because plasma volume expands more than red cell mass (which rises only ~20–30%), hemoglobin concentration falls — the physiological (dilutional) anemia of pregnancy, typically to about 11–12 g/dL, a normal finding, not iron deficiency alone.
Step 10 — Respiratory and renal adaptation. Progesterone increases the sensitivity of the medullary respiratory center to CO₂, raising tidal volume by about 30–40% and producing a chronic mild respiratory alkalosis (maternal PCO₂ falls from ~40 to ~30 mmHg), which favors CO₂ transfer from fetus to mother across the placenta. Renal plasma flow and glomerular filtration rate (GFR) rise by 30–50%, so creatinine and urea clearance increase and a "normal" nonpregnant creatinine (around 0.8–0.9 mg/dL) actually indicates renal impairment in pregnancy, where the expected value is closer to 0.4–0.6 mg/dL.
Step 11 — Onset of labor (parturition). Toward term, several converging signals push the system past the progesterone block. Fetal cortisol rises (a trigger conserved, though with different specific relay mechanisms, across mammals) and stimulates placental estrogen synthesis; the estrogen-to-progesterone ratio rises even without an absolute progesterone crash in most human pregnancies; myometrial gap junctions and oxytocin receptor density increase sharply near term; uterine stretch itself increases oxytocin receptor expression and prostaglandin (PGF2α, PGE2) synthesis in the decidua and myometrium. This creates a self-reinforcing positive feedback loop: contractions → cervical stretch → afferent signals to the hypothalamus → posterior pituitary oxytocin release (the Ferguson reflex) → stronger contractions → more cervical stretch, continuing until delivery, one of the few clear positive-feedback loops in normal physiology.
The evidence
Ascheim–Zondek and Friedman: bioassay proof that a trophoblastic hormone maintains pregnancy (1927–1931). Selmar Ascheim and Bernhard Zondek showed that injecting urine from pregnant women into immature female mice caused precocious ovarian follicular maturation and corpus luteum-like changes — the "A-Z test," the first reliable pregnancy test. Maurice Friedman later refined this using rabbits (ovulation induced within hours of injection, the "rabbit test" — origin of the phrase "the rabbit died," though the rabbit was always sacrificed to examine the ovaries regardless of result). These bioassays proved that a distinct, gonadotropic substance — later purified and named hCG — was present in pregnancy urine at levels far exceeding pituitary gonadotropins, and that it could act on ovarian tissue exactly as LH does. This was the founding evidence that a placental hormone, not a purely maternal one, drives corpus luteum maintenance.
Corpus luteum removal / ablation studies establishing the luteal-placental shift. Classic surgical and clinical studies (extending observations first made in animal models and confirmed in human obstetric practice through the mid-20th century) showed that surgical removal of the corpus luteum, or luteectomy, before roughly 7 weeks of human gestation reliably causes miscarriage due to progesterone withdrawal, whereas the same procedure performed after about 8–10 weeks does not terminate the pregnancy. Progesterone supplementation given after early luteectomy rescues the pregnancy, directly demonstrating that progesterone itself (not some other luteal factor) is the necessary output, and pinpointing the timing of the luteal-placental shift.
Diczfalusy and colleagues on the fetoplacental unit for estrogen synthesis (1960s). Egon Diczfalusy's biochemical studies showed that the placenta, incubated with radiolabeled progesterone or pregnenolone alone, could not produce significant estrogen because it lacks 17α-hydroxylase. Adding DHEA-S from the fetal adrenal gland as substrate, however, allowed robust estrogen (particularly estriol) production. Studies of anencephalic fetuses (with atrophic adrenal glands) and cases of placental sulfatase deficiency showed dramatically low maternal estriol, confirming that the fetal adrenal-hepatic axis, not the mother or placenta alone, supplies the essential precursor — establishing the fetoplacental unit concept and validating maternal estriol as a clinical marker of fetal status.
Liggins' fetal sheep experiments on the trigger for parturition (1960s–1970s). Graham Liggins, working with fetal lambs, found that infusing cortisol (or ACTH) into the fetus prematurely triggered labor, while fetal hypophysectomy (removing the pituitary, and thus cortisol production) or adrenalectomy prolonged gestation well past term. This established that in sheep, the fetal hypothalamic-pituitary-adrenal axis — not a purely maternal clock — signals the timing of birth by driving placental steroidogenesis toward estrogen. Human parturition triggers are more complex and less centrally cortisol-dependent, but Liggins' work is the founding experimental demonstration that the fetus actively signals its own delivery, reframing labor as a fetal-maternal, not purely maternal, decision — a landmark against any purely mechanical ("the uterus outgrows its blood supply") theory of labor onset.
Ferguson's demonstration of the reflex bearing his name (1941). James Ferguson showed in animal studies that mechanical distension of the cervix and vagina reflexively increases uterine contraction frequency and intensity via neurally mediated oxytocin release from the posterior pituitary — the Ferguson reflex. This experiment supplied the physiological missing link explaining why labor, once started, accelerates rather than plateaus: a genuine neuroendocrine positive-feedback circuit, one of very few in mammalian physiology, most others (temperature, blood glucose, pH) being negative feedback.
Worked examples
Example 1 — Interpreting a serial hCG and progesterone panel. A 29-year-old woman with a positive home pregnancy test at 5 weeks (by last menstrual period) presents with mild pelvic pain. Serum hCG is 1,200 mIU/mL; 48 hours later it is 1,550 mIU/mL — a rise of only about 29%, far below the ~66% minimum rise expected for a normally implanting intrauterine pregnancy at this hCG range. Serum progesterone is 8 ng/mL, well below the >20 ng/mL typically seen in viable pregnancies at this stage. Reasoning: normal early pregnancy shows hCG doubling roughly every 48–72 hours (mechanism: proliferating, healthy syncytiotrophoblast). A rise of only 29% over 48 hours, combined with low progesterone (suggesting an underperforming or ectopic-supported corpus luteum, since hCG signal strength — receptor occupancy and total trophoblast mass — is inadequate), strongly suggests either an early miscarriage or an ectopic pregnancy rather than a normal intrauterine gestation. This is exactly the logic clinicians use: because progesterone output is a direct downstream readout of adequate hCG-driven luteal support, a low progesterone with a poorly rising hCG converges on the same conclusion from two independent hormonal axes, prompting transvaginal ultrasound to locate the pregnancy before it is assumed to be failing or ectopic.
Example 2 — Cardiac output and the physiological basis of a murmur. A healthy 32-year-old woman at 28 weeks gestation has a resting heart rate of 88 bpm (baseline nonpregnant 72 bpm) and an echocardiographic stroke volume of 80 mL (baseline 65 mL). Her physician notes a soft systolic ejection murmur and physiological anemia with hemoglobin 10.8 g/dL (nonpregnant baseline 13.5 g/dL). Calculate cardiac output: CO = HR × SV. Nonpregnant: 72 × 65 mL = 4,680 mL/min ≈ 4.7 L/min. At 28 weeks: 88 × 80 mL = 7,040 mL/min ≈ 7.0 L/min. That is an increase of about 50%, consistent with the expected 30–50% rise in cardiac output during pregnancy, driven by estrogen-mediated vasodilation lowering afterload and progesterone/aldosterone-mediated volume expansion raising preload. The soft systolic murmur reflects increased flow across normal valves (a flow murmur) secondary to this elevated cardiac output and lower blood viscosity, not structural heart disease. The hemoglobin drop from 13.5 to 10.8 g/dL is expected dilutional anemia: plasma volume has expanded roughly 45%, while red cell mass has risen only about 20–25%, diluting hemoglobin concentration despite an absolute increase in total circulating hemoglobin mass — a distinction worth stating explicitly, since the number alone looks alarming out of context but reflects normal, adaptive volume expansion rather than blood loss or iron deficiency per se (though iron and folate needs do rise and should still be monitored and supplemented).
Common misconceptions & traps
| Misconception | Reality |
|---|---|
| "hCG is a stress hormone made by the mother's body in response to pregnancy." | hCG is made by fetal trophoblast tissue, not maternal tissue; it is a placental signal to the mother, and its presence is direct evidence of trophoblastic tissue, which is why it also rises in molar pregnancies and some germ-cell tumors. |
| "Physiological anemia of pregnancy means the mother is iron deficient." | It largely reflects dilution — plasma volume expands proportionally more than red cell mass — though true iron/folate deficiency can coexist and should be checked separately. |
| "Progesterone falls sharply right before human labor, just like in most other mammals." | In most mammals studied (sheep, goats), an absolute progesterone withdrawal triggers labor; in humans, progesterone often stays elevated and labor is better explained by a functional withdrawal — rising estrogen action and receptor changes shifting the estrogen:progesterone balance. |
| "The corpus luteum is needed for the entire pregnancy." | Only for the first 7–9 weeks; after the luteal-placental shift the placenta itself secretes enough progesterone, and the corpus luteum can be removed without ending the pregnancy. |
| "Gestational diabetes means the mother's pancreas is failing." | It reflects placental hPL/hormone-driven insulin resistance overwhelming a maternal beta-cell compensation that is otherwise adaptive; most women have functionally normal pancreatic reserve pre-pregnancy. |
| "Labor is purely a mechanical event — the uterus just outgrows its capacity." | Liggins' experiments showed labor onset is an actively signaled endocrine event, initiated in sheep by the fetal HPA axis, not simple mechanical overdistension. |
The scientist behind it
Origins · 1 minGraham C. Liggins and how this was discovered
Liggins trained as an obstetrician in New Zealand and turned to experimental physiology to answer a question clinicians could not: what actually starts labor? Working with pregnant ewes and their fetal lambs — an unusually tractable large-animal model because sheep pregnancies can be surgically instrumented in utero for weeks — he found that fetal hypophysectomy or adrenalectomy prolonged gestation indefinitely, while infusing ACTH or cortisol into the fetus triggered premature labor within days. This reframed labor as fetally initiated, driven by rising fetal cortisol acting on the placenta to boost estrogen synthesis, at least in sheep. The same research program led Liggins to test whether corticosteroids given to mothers threatening preterm labor could accelerate fetal lung maturation, drawing on the physiological logic that cortisol drives maturation of surfactant-producing cells — a therapy (antenatal corticosteroids) now used worldwide to prevent respiratory distress syndrome in premature infants, one of the most consequential translations of basic reproductive physiology into clinical practice.
Where this matters today
Serum and urine hCG assays remain the frontline pregnancy test worldwide and, tracked serially, are the standard tool for distinguishing viable intrauterine pregnancy from ectopic pregnancy or miscarriage, exactly as demonstrated in Worked Example 1. Maternal serum screening panels (hCG, estriol, and other analytes) are used in prenatal aneuploidy and neural tube defect screening, directly exploiting the fetoplacental hormone biology described here. Understanding hPL-driven insulin resistance underlies universal screening for gestational diabetes with an oral glucose tolerance test, and guides insulin or dietary management to prevent fetal macrosomia and neonatal hypoglycemia. Knowledge of progesterone's uterine-quiescence role motivates the clinical use of supplemental progesterone (vaginal or intramuscular) to prevent recurrent preterm birth in high-risk pregnancies. Liggins' discovery directly gave rise to antenatal corticosteroid therapy, now WHO-recommended for women at risk of preterm delivery between roughly 24 and 34 weeks, dramatically reducing neonatal respiratory distress syndrome and mortality. Oxytocin (synthetic, "Pitocin") and prostaglandin analogs (misoprostol, dinoprostone), modeled directly on the natural labor-initiation pathway, are used clinically to induce or augment labor. Finally, understanding normal cardiovascular and renal adaptation — the expected rises in cardiac output, GFR, and plasma volume — underlies correct interpretation of vital signs and lab values in obstetric triage, and is essential for recognizing early preeclampsia, a leading global cause of maternal mortality, before it progresses to eclampsia. This physiology also frames the transition into Lactation, where a further hormonal handoff — falling progesterone and rising prolactin after delivery — initiates milk production.
Ask the tutor: How does the mechanism of labor onset differ between humans and other mammals, and why does that matter for treating preterm labor?
Why does hCG level, rather than progesterone, define the classic home pregnancy test?
hCG is produced specifically and abundantly by trophoblast tissue starting within days of implantation, reaching easily detectable urine concentrations (tens of mIU/mL) within about two weeks of conception, and it is structurally distinct enough from other glycoprotein hormones (LH, FSH, TSH) that antibody-based assays can detect it specifically. Progesterone, by contrast, is also produced during the normal luteal phase of every ovarian cycle regardless of pregnancy, so an elevated progesterone level alone cannot distinguish pregnancy from a normal post-ovulatory, non-pregnant state. hCG is therefore the unique, unambiguous molecular signature of trophoblastic tissue, which is why it is the analyte chosen for home and clinical pregnancy tests, and also why elevated hCG outside pregnancy raises suspicion of trophoblastic or germ-cell tumors.
What actually causes gestational diabetes mechanistically?
The placenta secretes human placental lactogen (hPL) along with progesterone, cortisol, and placental growth hormone, all of which reduce the sensitivity of maternal muscle and adipose tissue to insulin, an adaptation that spares circulating glucose and free fatty acids for fetal use, especially during maternal fasting. In most pregnancies, maternal pancreatic beta cells compensate by increasing insulin secretion two- to threefold, keeping blood glucose normal. Gestational diabetes arises when a woman's beta-cell reserve cannot keep pace with this rising insulin resistance, usually becoming apparent in the second half of pregnancy as placental hormone output peaks, leading to maternal hyperglycemia, fetal hyperinsulinemia, and risks of macrosomia and neonatal hypoglycemia after delivery once the placental hormone supply is abruptly removed.
Does progesterone actually fall before human labor, as it does in sheep?
Not necessarily in absolute terms. In sheep, goats, and several other mammals, a sharp drop in circulating progesterone directly precedes and triggers labor, and this was the original model system used to establish the endocrinology of parturition. In humans, plasma progesterone often remains high right up to delivery, so investigators instead invoke a "functional progesterone withdrawal": changes in progesterone receptor isoform expression, falling myometrial responsiveness to progesterone, and a rising ratio of estrogen to progesterone action at the level of the uterus, even without a large systemic hormone drop. This is one reason progesterone supplementation can still help prevent preterm labor in humans — it reinforces receptor-level quiescence signaling even when circulating levels are already high.
Why is maternal blood pressure lower in mid-pregnancy despite a large rise in blood volume and cardiac output?
Even though blood volume and cardiac output both rise substantially, systemic vascular resistance falls even more, driven by estrogen- and progesterone-mediated vasodilation, nitric oxide release from vascular endothelium, and the very low-resistance placental circulation acting as an enormous parallel vascular bed. Because blood pressure equals cardiac output multiplied by total peripheral resistance, a large resistance drop can outweigh a rising cardiac output, producing the well-documented mid-pregnancy dip in blood pressure (a nadir typically around 20–24 weeks) before pressure gradually rises again toward term as resistance partially recovers. This is why a mid-pregnancy blood pressure "in the normal nonpregnant range" can actually represent a meaningful, and expected, drop from a woman's individual pre-pregnancy baseline.
How is the Ferguson reflex different from a typical negative feedback loop in physiology?
Most homeostatic physiology (blood glucose regulation, thermoregulation, blood pressure baroreflexes) works by negative feedback: a deviation triggers a response that opposes and corrects the deviation, restoring a set point. The Ferguson reflex works in the opposite direction: cervical and vaginal stretch caused by a contraction triggers oxytocin release, which causes a stronger contraction, causing more stretch, which triggers still more oxytocin — each cycle amplifies rather than corrects the initial signal. This positive feedback architecture is exactly what is needed for an event, like delivering a baby, that must proceed rapidly to completion once started rather than being damped back toward a resting baseline, and it terminates naturally once the mechanical stimulus (the fetus in the birth canal) is removed at delivery.
Why is maternal serum estriol a marker of fetal well-being rather than purely maternal hormone status?
Estriol synthesis requires DHEA-S produced by the fetal adrenal gland, further processed by the fetal liver, and finally aromatized by the placenta; the maternal ovary and adrenal contribute comparatively little precursor. This means a healthy, functioning fetal adrenal-hepatic axis is essential to normal estriol output, so an unexpectedly low maternal estriol level (adjusted for gestational age) can indicate fetal adrenal insufficiency, placental sulfatase deficiency, or fetal compromise, rather than any maternal ovarian or adrenal problem. This is precisely why estriol, unlike progesterone, was incorporated into some prenatal screening panels as an indirect readout of fetal, not maternal, physiological status.
Can pregnancy be sustained without a corpus luteum from the very start?
No — before roughly 7 weeks of gestation the fetoplacental unit has not yet matured enough to independently secrete adequate progesterone, so pregnancies conceived via assisted reproduction techniques that bypass normal corpus luteum formation, or in which the corpus luteum is surgically removed early, require exogenous progesterone supplementation to prevent miscarriage. After the luteal-placental shift is complete, around 8–10 weeks, the placenta's own steroidogenic capacity is sufficient, and corpus luteum removal (or its natural regression) no longer threatens the pregnancy, which is why fertility clinics generally continue progesterone support only through roughly the first trimester.